Ceredex Value Advisors’s Johnson & Johnson JNJ Stock Holding History

Ceredex Value Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-238,735	Closed	-$44.3M	–	175
2025 Q3	$44.3M	Sell	238,735 -69,665	-23%	-$11.9M	1.03%	30
2025 Q2	$47.1M	Buy	+308,400	New	+$47.4M	1.01%	24
2024 Q4	–	Sell	-252,050	Closed	-$40.8M	–	169
2024 Q3	$40.8M	Sell	252,050 -20,890	-8%	-$3.33M	0.8%	49
2024 Q2	$39.9M	Sell	272,940 -105,046	-28%	-$15.6M	0.75%	50
2024 Q1	$59.8M	Buy	377,986 +49,176	+15%	+$7.83M	1.05%	31
2023 Q4	$51.5M	Buy	328,810 +21,499	+7%	+$3.3M	0.89%	40
2023 Q3	$47.9M	Sell	307,311 -155,922	-34%	-$25.7M	0.84%	48
2023 Q2	$76.7M	Buy	+463,233	New	+$74.8M	1.24%	25

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ceredex Value Advisors's JNJ Position: Q4 2025 in Review

Ceredex Value Advisors sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 238,735 shares — an estimated $44.3M sold.

Ceredex Value Advisors first reported a position in JNJ in Q2 2023 and held it in 8 quarters. The position peaked at $76.7M in Q2 2023. 4,539 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Ceredex Value Advisors reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
Ceredex Value Advisors sold 238,735 Johnson & Johnson shares in Q4 2025, an estimated $44.3M.
Ceredex Value Advisors first reported a position in Johnson & Johnson in Q2 2023 and held it in 8 quarters.
Ceredex Value Advisors's Johnson & Johnson position peaked at $76.7M in Q2 2023.
4,539 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Ceredex Value Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.